HIV protease inhibitor ritonavir: A more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833

Biochemical Pharmacology

Volumn 57, Issue 10, 1999, Pages 1147-1152

  Drewe, J ürgen ^a   Gutmann, Heike ^a   Fricker, Gert ^b   Török, Michael ^a   Beglinger, Christoph ^a   Huwyler, J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

AIDS; AIDS dementia complex; Blood brain barrier; HIV protease inhibitors; Indinavir; Nelfinavir; P glycoprotein; Ritonavir; Saquinavir; SDZ PSC 833

Indexed keywords

CARBON 14; GLYCOPROTEIN P; ISOPROTEIN; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; VALSPODAR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; BRAIN CAPILLARY; CAPILLARY ENDOTHELIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG UPTAKE; ENDOTHELIUM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; MONOLAYER CULTURE; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWINE;

EID: 0033562673     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00026-X     Document Type: Article

References (18)

1. Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., Cleary P. The brain and AIDS Central nervous system HIV-1 infection and AIDS dementia complex . Science. 239:1988;586-592.
2. Lipton S.A., Gendelman H.E. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med. 332:1995;934-940.
3. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A.A.M., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77:1994;491-502.
4. Kim R.B., Fromm M.F., Wandel C., Leake B., Wood A.J., Roden D.M., Wilkinson G.R. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest. 101:1998;289-294.
5. Alsenz J., Steffen H., Alex R. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. Pharmacol Res. 15:1998;423-428.
6. Glynn S.L., Yazdanian M. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents. J Pharm Sci. 87:1998;306-310.
7. Kempf D.J., Marsh K.C., Kumar G., Rodrigues A.D., Denissen J.F., McDonald E., Kukulka M.J., Hsu A., Granneman G.R., Baroldi P.A., Sun E., Pizzuti D., Plattner J.J., Norbeck D.W., Leonard J.M. Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrob Agents Chemother. 41:1997;654-660.
8. Merry C., Barry M.G., Mulcahy F., Ryan M., Heavey J., Tjia J.F., Gibbons S.E., Breckenridge A.M., Back D.J. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS. 11:1997;F29-F33.
9. Hsu A., Granneman G.R., Cao G., Carothers L., el-Shourbagy T., Baroldi P., Erdman K., Brown F., Sun E., Leonard J.M. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir. Clin Pharmacol Ther. 63:1998;453-464.
10. Huwyler J., Drewe J., Klusemann C., Fricker G. Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Pharmacol. 118:1996;1879-1885.
11. Audus K.L., Borchardt R.T. Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann NY Acad Sci. 507:1987;9-18.
12. Boesch D., Gaveriaux C., Jachez B., Pourtier-Manzanedo A., Bollinger P., Loor F. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res. 51:1991;4226-4233.
13. Childs S., Ling V. Duplication and evolution of the P-glycoprotein genes in pig. Biochim Biophys Acta. 1307:1996;205-212.
14. Kivistö K.T., Griese E.-U., Fritz P., Linder A., Hakkola J., Raunio H., Beaune P., Kroemer H.K. Expression of cytochrome P 450 3A enzymes in human lung A combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours . Naunyn Schmiedeberg's Arch Pharmacol. 353:1996;207-212.
15. SPSS for Windows. 1997;SPSS Inc, Chicago IL.
16. Lee C.G., Gottesman M.M., Cardarelli C.O., Ramachandra M., Jeang K.T., Ambudkar S.V., Pastan I., Dey S. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry. 37:1998;3594-3601.
17. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 62:1993;385-427.
18. Pialoux G., Fournier S., Moulignier A., Poveda J.D., Clavel F., Dupont B. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS. 11:1997;1302-1303.